Artelo Biosciences aims to accelerate the development and commercialization of endocannabinoid system modulating therapeutics.
Artelo Biosciences has raised $11.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2026.
Artelo Biosciences's investors include Bartosz Lipiński.
Artelo Biosciences is headquartered in La Jolla, United States.
Artelo Biosciences aims to accelerate the development and commercialization of endocannabinoid system modulating therapeutics.
Artelo Biosciences is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Artelo Biosciences — Funding & Investors." VCBacked, March 27, 2026, https://www.vcbacked.co/company/artelo-biosciences. Accessed November 15, 2026.
VCBacked. (2026). Artelo Biosciences — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/artelo-biosciences
{{cite web |title=Artelo Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/artelo-biosciences |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Artelo Biosciences? Request a listing update